Autres langues BioPorto A/S

Actions

Temps Différé Nasdaq Copenhagen Autres places de cotation 12:20:57 08/05/2024			Varia. 5j.	Varia. 1 janv.
1,698 ^DKK	+16,14 %		+30,41 %	-18,76 %

08:21	Bioporto A/S donne des prévisions de recettes pour 2024	CI
10/04	BioPorto nomme un nouveau directeur juridique	MT

First Quarter 2024: Strong growth in US sales of The NGAL Test	08:22
Bioporto A/S Provides Revenue Guidance for 2024	08:21
Resolutions of Annual Geneal Meeting	30/04
Grant of warrants	23/04
BioPorto Names New Chief Legal Officer	10/04
BioPorto A/S Appoints Chief Legal Officer	10/04
Bioporto A/S Appoints Gry Louise Husby Larsen as Chief Legal Officer and Member of the Executive Management Team, Effective as of April 15, 2024	10/04
New Board Candidate for the upcoming Annual Geneal Meeting	05/04
Bioporto A/S Announces Tonni Bülow-Nielsennot to Stand for Election	05/04
Notice convening the Annual General Meeting in BioPorto A/S	04/04
Correction: BioPorto Announces Annual Results for 2023	04/04
BioPorto Announces Annual Results for 2023	04/04
BioPorto A/S Reports Earnings Results for the Full Year Ended December 31, 2023	04/04
BioPorto Makes Interim CEO Permanent	02/04
BioPorto appoints Peter Mørch Eriksen as permanent Group Chief Executive Officer	02/04
BioPorto A/S Appoints Peter Mørch Eriksen as Permanent Group CEO	02/04
Bioporto A/S Announces Peter Mørch Eriksen Will Not Stand for Re-Election to the Board of Directors	02/04
BioPorto announces preliminary results for 2023 and provides strategic update for the period 2024-2026	22/02
BioPorto A/S Provides Revenue Guidance for the Full Year 2024	22/02
Roche : collaboration étendue avec le danois BioPorto	20/02

Aucun résultat pour cette recherche